Evidence map›Paper›PMID 42793994›Full record

ArticleFoods (Basel, Switzerland)2026

Highly Sustainable Plant and Yeast Hydrolysate-Based Alternative for Basal Medium Supports Long-Term

Lisa Schenzle, Shashank Goyal, Regina Leber, Harald Pichler, Aleksandra Fuchs

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa Schenzleacib-Austrian Centre of Industrial Biotechnology, 8010 Graz, Austria.ORCID 0009-0008-0319-4855
Shashank GoyalEurA AG, 99084 Erfurt, Germany.ORCID 0000-0002-4258-2083
Regina Leberacib-Austrian Centre of Industrial Biotechnology, 8010 Graz, Austria.
Harald Pichleracib-Austrian Centre of Industrial Biotechnology, 8010 Graz, Austria.ORCID 0000-0001-6043-2137
Aleksandra Fuchsacib-Austrian Centre of Industrial Biotechnology, 8010 Graz, Austria.ORCID 0009-0000-0042-3343

Funding

European Union 101136749
6 · The paper itself

Abstract

The production of cultured meat will require large quantities of cell culture medium, presenting challenges related to high costs and limited sustainability of both protein-based components and other ingredients of the basal medium. To date, most research has focused on substituting and optimizing protein-based medium components, leading to significant progress in reducing costs associated with growth factors and serum albumin. However, the basal medium-containing amino acids, vitamins, carbon sources, and microelements-is equally essential. While some efforts have been made to optimize its composition, the environmental impact of using chemically fully defined mixtures remains considerable, and cost reductions are challenging. In this study, we introduce a novel approach to basal medium production by utilizing a mixture of partially hydrolyzed plant and yeast biomass. Our results demonstrate that hydrolysate-based basal medium (HBBM) performs comparably to chemically fully defined basal medium during proliferation and differentiation of bovine satellite cells. Furthermore, a comparative life cycle assessment was performed to explore the environmental impacts of replacing chemically fully defined medium with HBBM. The analysis showed potential reduction in environmental impacts, highlighting the relevance of basal medium formulation as a key element to influence ecological sustainability.

Indexed as

basal medium substitutioncultured meatDMEM/F12hydrolysate-based basal mediumlife cycle assessmentserum-free media

Identifiers

PMID42793994
PMCPMC13605773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.